Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Hepatitis Monthly|June 28, 2013
Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B PatientsByung Kook Kim, Soon Young Ko, So Young Kwon, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|February 3, 2016
Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablationHyun Ah Chung, Jeong-Han Kim, Young Hwang, et al.
World Journal of Gastroenterology|March 6, 2010
Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shiftHee Won Moon, Jin Hee Cho, Mina Hur, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|October 24, 2015
[A Case of Delayed-onset Multiple Metastatic Infection following Liver Abscess]Kang Hoon Lee, Sun Young Moon, In Ae Kim, et al.
Clinical and Molecular Hepatology|December 31, 2014
Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathySoon Young Ko, Byung Kook Kim, Dong Wook Kim, et al.
Hepatology International|July 24, 2015
Value of the APASL severity score in patients with acute variceal bleeding: a single center experienceGo Heun Kim, Jeong Han Kim, Yong Jin Kim, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2022
Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two CentersJung Hun Kim, Jeong Han Kim, Won Hyeok Choe, et al.
Analytica Chimica Acta|March 26, 2011
Determination of hexavalent chromium (Cr(VI)) in plastics using organic-assisted alkaline extractionJeong Sook Kim, Young Rak Choi, Youn Sung Kim, et al.
The Korean Journal of Hepatology|January 3, 2009
[Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation]Byung Kook Kim, So Young Kwon, Soon Young Ko, et al.
Clinical and Molecular Hepatology|April 24, 2014
The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascitesJun Jae Kim, Jeong Han Kim, Ja Kyung Koo, et al.
Pageof 14